In a report released yesterday, Mark Massaro from BTIG reiterated a Buy rating on CareDx (CDNA – Research Report), with a price target of ...

CareDx CDNA shares ended the last trading session 11.2% higher at $24.91. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

Data was gathered from key stakeholders, including Fordham students, along the five major Commercial Corridors in Fordham Manor - Fordham Road, Jerome Avenue, Grand Concourse, Webster Avenue, and ...

CareDx CDNA shares rallied 6.1% in the last trading session to close at $25.07. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session.

CareDx (CDNA) reported $86.58 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 32%. EPS of $0.18 for the same period compares to -$0.17 a year ago.

Tesla stock is dropping on Monday after a rough few weeks for the automaker. Tesla (TSLA) received a price target cut from Mizuho analysts, who cut their forecasts from $515 to $430 per share ...

CareDx (CDNA) announced that AlloSure is now commercially available for pediatric heart transplant patients of all ages and patients who have ...

Good afternoon, everyone. Welcome to the CareDx, Inc. Fourth Quarter and Fiscal Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only-mode. Later, you will have ...

CareDx Inc (CDNA) reports a robust 32% revenue increase and strategic expansions, while navigating potential challenges in ...